SG11201509427RA - 4'-azido, 3'-deoxy-3'-fluoro substituted nucleoside derivatives - Google Patents
4'-azido, 3'-deoxy-3'-fluoro substituted nucleoside derivativesInfo
- Publication number
- SG11201509427RA SG11201509427RA SG11201509427RA SG11201509427RA SG11201509427RA SG 11201509427R A SG11201509427R A SG 11201509427RA SG 11201509427R A SG11201509427R A SG 11201509427RA SG 11201509427R A SG11201509427R A SG 11201509427RA SG 11201509427R A SG11201509427R A SG 11201509427RA
- Authority
- SG
- Singapore
- Prior art keywords
- azido
- deoxy
- fluoro substituted
- substituted nucleoside
- nucleoside derivatives
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
- C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361824034P | 2013-05-16 | 2013-05-16 | |
PCT/US2014/038288 WO2014193663A1 (en) | 2013-05-16 | 2014-05-15 | 4'-azido, 3'-deoxy-3'-fluoro substituted nucleoside derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201509427RA true SG11201509427RA (en) | 2015-12-30 |
Family
ID=51895939
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201509427RA SG11201509427RA (en) | 2013-05-16 | 2014-05-15 | 4'-azido, 3'-deoxy-3'-fluoro substituted nucleoside derivatives |
Country Status (19)
Country | Link |
---|---|
US (2) | US9249176B2 (en) |
EP (1) | EP2996696A4 (en) |
JP (1) | JP2016519146A (en) |
KR (1) | KR20160039154A (en) |
CN (1) | CN105307661A (en) |
AU (1) | AU2014272055A1 (en) |
BR (1) | BR112015028765A2 (en) |
CA (1) | CA2912684A1 (en) |
CL (1) | CL2015003358A1 (en) |
CR (1) | CR20150649A (en) |
EA (1) | EA201592185A1 (en) |
HK (2) | HK1217295A1 (en) |
MA (1) | MA38678A1 (en) |
MX (1) | MX2015015781A (en) |
PE (1) | PE20160119A1 (en) |
PH (1) | PH12015502589A1 (en) |
SG (1) | SG11201509427RA (en) |
WO (1) | WO2014193663A1 (en) |
ZA (1) | ZA201509055B (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MA38678A1 (en) * | 2013-05-16 | 2017-07-31 | Riboscience Llc | Nucleoside derivatives 4'-azido, 3'-deoxy-3'-fluoro substituted |
RU2740760C2 (en) * | 2016-03-25 | 2021-01-20 | Цзянсу Тасли Дии Фармасьютикал Ко., Лтд. | Prodrug based on uridine phosphoramide, a method for production thereof and use thereof in medicine |
CN109562113A (en) | 2016-05-10 | 2019-04-02 | C4医药公司 | Loop coil degron body for target protein degradation |
CN109641874A (en) | 2016-05-10 | 2019-04-16 | C4医药公司 | C for target protein degradation3The glutarimide degron body of carbon connection |
WO2017197055A1 (en) | 2016-05-10 | 2017-11-16 | C4 Therapeutics, Inc. | Heterocyclic degronimers for target protein degradation |
AR112702A1 (en) * | 2017-09-21 | 2019-11-27 | Riboscience Llc | 4'-FLUORO-2'-METHYL SUBSTITUTED NUCLEOSIDE DERIVATIVES AS HCV RNA REPLICATION INHIBITORS |
Family Cites Families (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU498131B2 (en) | 1974-02-26 | 1979-02-15 | Ciba-Geigy Ag | Production of cephems by cyclization |
US4147864A (en) | 1975-02-20 | 1979-04-03 | Ciba-Geigy Corporation | Process for the manufacture of 7β-amino-3-cephem-3-ol-4 carboxylic acid compounds |
US4322347A (en) | 1978-04-03 | 1982-03-30 | Bristol-Myers Company | 2-Carbamoyloxymethyl-penicillin derivatives |
WO1986006380A1 (en) | 1985-04-30 | 1986-11-06 | Takeda Chemical Industries, Ltd. | Antibacterial compounds, use and preparation thereof |
JPS6422823A (en) * | 1987-07-17 | 1989-01-25 | Asahi Glass Co Ltd | Antiulcer agent |
US5449664A (en) | 1988-11-21 | 1995-09-12 | Syntex (U.S.A.) Inc. | Antiviral agents |
US6054472A (en) | 1996-04-23 | 2000-04-25 | Vertex Pharmaceuticals, Incorporated | Inhibitors of IMPDH enzyme |
US5807876A (en) | 1996-04-23 | 1998-09-15 | Vertex Pharmaceuticals Incorporated | Inhibitors of IMPDH enzyme |
NZ332405A (en) | 1996-04-23 | 2000-06-23 | Vertex Pharma | oxazolyl, thiazolyl or phenyl urea derivatives as inhibitors of inosine monophosphate dehydrogenase enzyme |
SK286105B6 (en) | 1996-10-18 | 2008-03-05 | Vertex Pharmaceuticals Incorporated | Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease, pharmaceutical composition and their use |
GB9623908D0 (en) | 1996-11-18 | 1997-01-08 | Hoffmann La Roche | Amino acid derivatives |
WO1998040381A1 (en) | 1997-03-14 | 1998-09-17 | Vertex Pharmaceuticals Incorporated | Inhibitors of impdh enzyme |
US6010848A (en) | 1997-07-02 | 2000-01-04 | Smithkline Beecham Corporation | Screening methods using an atpase protein from hepatitis C virus |
EP1012180B1 (en) | 1997-08-11 | 2004-12-01 | Boehringer Ingelheim (Canada) Ltd. | Hepatitis c inhibitor peptide analogues |
DE69925918T2 (en) | 1998-07-27 | 2006-05-11 | Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. | DIKETIC ACID DERIVATIVES AS POLYMERASES INHIBITORS |
US6323180B1 (en) | 1998-08-10 | 2001-11-27 | Boehringer Ingelheim (Canada) Ltd | Hepatitis C inhibitor tri-peptides |
WO2000010573A1 (en) | 1998-08-21 | 2000-03-02 | Viropharma Incorporated | Compounds, compositions and methods for treating or preventing viral infections and associated diseases |
AU751201B2 (en) | 1998-09-04 | 2002-08-08 | Viropharma Incorporated | Methods for treating or preventing viral infections and associated diseases |
BR9913935A (en) | 1998-09-25 | 2001-06-19 | Viropharma Inc | Methods of treatment and prevention of infection caused by at least one virus of the family of flaviviridae and disease associated with said infection in a living host |
NZ514540A (en) | 1999-03-19 | 2003-11-28 | Vertex Pharma | Phenyl derivative useful as inhibitors of IMPDH enzyme |
EP1225899A2 (en) | 1999-11-04 | 2002-07-31 | Virochem Pharma Inc. | Method for the treatment or prevention of flaviviridae viral infection using nucleoside analogues |
JP2004509066A (en) | 2000-05-10 | 2004-03-25 | スミスクライン・ビーチャム・コーポレイション | New anti-infective drug |
US6448281B1 (en) | 2000-07-06 | 2002-09-10 | Boehringer Ingelheim (Canada) Ltd. | Viral polymerase inhibitors |
SV2003000617A (en) | 2000-08-31 | 2003-01-13 | Lilly Co Eli | INHIBITORS OF PROTEASA PEPTIDOMIMETICA REF. X-14912M |
JPWO2002051425A1 (en) * | 2000-12-26 | 2004-04-22 | 三菱ウェルファーマ株式会社 | Hepatitis C treatment |
MXPA03011452A (en) | 2001-06-11 | 2005-03-07 | Virochem Pharma Inc | Thiophene derivatives as antiviral agents for flavivirus infection. |
CA2449999C (en) | 2001-06-11 | 2012-07-31 | Shire Biochem Inc. | Compounds and methods for the treatment or prevention of flavivirus infections |
GB0114286D0 (en) * | 2001-06-12 | 2001-08-01 | Hoffmann La Roche | Nucleoside Derivatives |
AR035543A1 (en) | 2001-06-26 | 2004-06-16 | Japan Tobacco Inc | THERAPEUTIC AGENT FOR HEPATITIS C THAT INCLUDES A CONDENSED RING COMPOUND, CONDENSED RING COMPOUND, PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS, BENZIMIDAZOL, THIAZOL AND BIFENYL COMPOUNDS USED AS INTERMEDIARY COMPARTMENTS OF COMPARTMENTS |
JP4558314B2 (en) | 2001-07-20 | 2010-10-06 | ベーリンガー インゲルハイム (カナダ) リミテッド | Viral polymerase inhibitor |
EP2335700A1 (en) | 2001-07-25 | 2011-06-22 | Boehringer Ingelheim (Canada) Ltd. | Hepatitis C virus polymerase inhibitors with a heterobicylic structure |
JP2005511573A (en) | 2001-11-02 | 2005-04-28 | グラクソ グループ リミテッド | 4- (5-membered) -heteroarylacylpyrrolidine derivatives as HCV inhibitors |
DE60221875T2 (en) | 2001-11-02 | 2007-12-20 | Glaxo Group Ltd., Greenford | 4- (6-LOW) HETEROARYL ACYL-PYRROLIDINE DERIVATIVES AS HCV INHIBITORS |
EP1440068A1 (en) | 2001-11-02 | 2004-07-28 | Glaxo Group Limited | Acyl dihydro pyrrole derivatives as hcv inhibitors |
CA2488534A1 (en) | 2002-06-21 | 2003-12-31 | Merck & Co., Inc. | Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase |
AU2003259735A1 (en) | 2002-08-08 | 2004-02-25 | Sirna Therapeutics, Inc. | Small-mer compositions and methods of use |
WO2004096235A2 (en) | 2003-04-25 | 2004-11-11 | Gilead Sciences, Inc. | Anti-cancer phosphonate analogs |
US20040259934A1 (en) | 2003-05-01 | 2004-12-23 | Olsen David B. | Inhibiting Coronaviridae viral replication and treating Coronaviridae viral infection with nucleoside compounds |
ES2456702T3 (en) * | 2003-05-09 | 2014-04-23 | Boehringer Ingelheim International Gmbh | Hepatitis C virus NS5B polymerase inhibitor binding pocket |
GB0317009D0 (en) | 2003-07-21 | 2003-08-27 | Univ Cardiff | Chemical compounds |
JP4902361B2 (en) | 2004-01-30 | 2012-03-21 | メディヴィル・アクチエボラーグ | HCVNS-3 serine protease inhibitor |
EP1828145A4 (en) | 2004-12-10 | 2009-08-19 | Univ Emory | 2' and 3' - substituted cyclobutyl nucleoside analogs for the treatment of viral infections and abnormal cellular proliferation |
JP2009504704A (en) * | 2005-08-15 | 2009-02-05 | エフ.ホフマン−ラ ロシュ アーゲー | Antiviral 4'-substituted pronucleotide phosphoramidate |
WO2007095269A2 (en) | 2006-02-14 | 2007-08-23 | Merck & Co., Inc. | Nucleoside aryl phosphoramidates for the treatment of rna-dependent rna viral infection |
GB2442001A (en) | 2006-08-11 | 2008-03-26 | Chembiotech | Nanoparticle - i-motif nucleic acid bioconjugates |
US8329159B2 (en) | 2006-08-11 | 2012-12-11 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
WO2008085508A2 (en) | 2007-01-05 | 2008-07-17 | Merck & Co., Inc. | Nucleoside aryl phosphoramidates for the treatment of rna-dependent rna viral infection |
GB0709791D0 (en) | 2007-05-22 | 2007-06-27 | Angeletti P Ist Richerche Bio | Antiviral agents |
WO2012012465A1 (en) | 2010-07-19 | 2012-01-26 | Clarke, Michael, O'neil Hanrahan | Methods for the preparation of diasteromerically pure phosphoramidate prodrugs |
WO2012040127A1 (en) | 2010-09-22 | 2012-03-29 | Alios Biopharma, Inc. | Substituted nucleotide analogs |
CA2812962C (en) | 2010-09-22 | 2020-03-31 | Alios Biopharma, Inc. | Azido nucleosides and nucleotide analogs |
WO2012048013A2 (en) * | 2010-10-06 | 2012-04-12 | Inhibitex, Inc. | Phosphorodiamidate derivatives of guanosine nucleoside compounds for treatment of viral injections |
LT2794628T (en) * | 2011-12-20 | 2017-07-10 | Riboscience Llc | 4`-azido-3`-fluoro substituted nucleoside derivatives as inhibitors of hcv rna replication |
MA38678A1 (en) * | 2013-05-16 | 2017-07-31 | Riboscience Llc | Nucleoside derivatives 4'-azido, 3'-deoxy-3'-fluoro substituted |
-
2014
- 2014-05-15 MA MA38678A patent/MA38678A1/en unknown
- 2014-05-15 SG SG11201509427RA patent/SG11201509427RA/en unknown
- 2014-05-15 AU AU2014272055A patent/AU2014272055A1/en not_active Abandoned
- 2014-05-15 WO PCT/US2014/038288 patent/WO2014193663A1/en active Application Filing
- 2014-05-15 EA EA201592185A patent/EA201592185A1/en unknown
- 2014-05-15 CN CN201480033073.9A patent/CN105307661A/en active Pending
- 2014-05-15 MX MX2015015781A patent/MX2015015781A/en unknown
- 2014-05-15 BR BR112015028765A patent/BR112015028765A2/en not_active IP Right Cessation
- 2014-05-15 US US14/279,188 patent/US9249176B2/en active Active
- 2014-05-15 PE PE2015002404A patent/PE20160119A1/en not_active Application Discontinuation
- 2014-05-15 JP JP2016514105A patent/JP2016519146A/en active Pending
- 2014-05-15 KR KR1020157035496A patent/KR20160039154A/en not_active Application Discontinuation
- 2014-05-15 CA CA2912684A patent/CA2912684A1/en not_active Abandoned
- 2014-05-15 EP EP14804722.8A patent/EP2996696A4/en not_active Withdrawn
-
2015
- 2015-11-13 CL CL2015003358A patent/CL2015003358A1/en unknown
- 2015-11-16 PH PH12015502589A patent/PH12015502589A1/en unknown
- 2015-12-08 CR CR20150649A patent/CR20150649A/en unknown
- 2015-12-11 ZA ZA2015/09055A patent/ZA201509055B/en unknown
-
2016
- 2016-02-02 US US15/013,173 patent/US9694028B2/en not_active Expired - Fee Related
- 2016-05-10 HK HK16105295.3A patent/HK1217295A1/en unknown
- 2016-07-11 HK HK16108066.4A patent/HK1219901A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
MA38678A1 (en) | 2017-07-31 |
EA201592185A1 (en) | 2016-05-31 |
ZA201509055B (en) | 2017-03-29 |
JP2016519146A (en) | 2016-06-30 |
US9694028B2 (en) | 2017-07-04 |
PE20160119A1 (en) | 2016-02-24 |
PH12015502589A1 (en) | 2016-02-29 |
US9249176B2 (en) | 2016-02-02 |
HK1217295A1 (en) | 2017-01-06 |
CA2912684A1 (en) | 2014-12-04 |
US20160220596A1 (en) | 2016-08-04 |
CN105307661A (en) | 2016-02-03 |
KR20160039154A (en) | 2016-04-08 |
BR112015028765A2 (en) | 2017-07-25 |
CL2015003358A1 (en) | 2016-10-14 |
AU2014272055A1 (en) | 2015-12-24 |
MX2015015781A (en) | 2016-06-02 |
US20140341848A1 (en) | 2014-11-20 |
EP2996696A4 (en) | 2016-12-21 |
HK1219901A1 (en) | 2017-04-21 |
WO2014193663A1 (en) | 2014-12-04 |
CR20150649A (en) | 2016-03-09 |
EP2996696A1 (en) | 2016-03-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL274901A (en) | Substituted nucleosides, nucleotides and analogs thereof | |
HRP20182030T1 (en) | Substituted nucleosides, nucleotides and analogs thereof | |
HK1224229A1 (en) | Substituted nucleosides, nucleotides and analogs thereof | |
HK1222178A1 (en) | Substituted nucleosides, nucleotides and analogs thereof | |
IL245014A0 (en) | Substituted nucleosides, nucleotides and analogs thereof | |
HK1220463A1 (en) | Modified nucleosides or nucleotides | |
HK1216535A1 (en) | Substituted nucleosides, nucleotides and analogs thereof | |
IL242605B (en) | 4'-fluoro-2'-methyl substituted nucleoside derivatives | |
EP2957567A4 (en) | Nucleoside and nucleotide, having nitrogen-containing hetercycle structure | |
ZA201509055B (en) | 4'-azido, 3'-deoxy-3'-fluoro substituted nucleoside derivatives |